<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">The second phase, or moderate pneumonia, occurs approximately in 15% of the patients and from the tenth day the symptoms begin to worsen with dyspnea, cough, and oxygen saturation decrease [
 <xref ref-type="bibr" rid="CR3">3</xref>], with signs and symptoms suggesting progession for lower respiratory tract infection. Laboratory evaluation reveals an increase of inflammatory reagents such as C-reactive protein (CRP), ferritin, and D-dimer, evidencing an important inflammatory activity and a prothrombotic component of the disease. Additionally, a chest computed tomography (CT) may demonstrate a bilateral peripheral pulmonary infiltrate in a well-defined ground-glass pattern, indicating the development of viral pneumonia [
 <xref ref-type="bibr" rid="CR3">3</xref>].
</p>
